LEXX earnings: next date and EPS history
Lexaria Bioscience Corp.
Is LEXX halal? — screening resultHalal
Next report
US date: November 25, 2026· in 39 days
Time not announced · Session: 19:30 — 02:00 Tashkent
- EPS estimate (consensus)
- −$0.90(1 analysts)
- Quarter ending
- Aug 2026
Per the Nasdaq calendar. Date from the Nasdaq earnings calendar; the company may not have officially confirmed it yet.
At a glance
Over the last 8 quarters: 4 beats and 4 misses on EPS. Median surprise: −13.5%.
Around the report the price moved ±5.8% on average (largest ±12.1%); up 4 times, down 4 times.
EPS: estimate vs actual
Two bars per quarter: grey — analysts' estimate, coloured — actual EPS (green — beat, red — miss).
Post-earnings price move
Change from the close before the report to the close after it.
Last 8 quarters
| Report date | Quarter ending | Estimate | Actual | Surprise | Result | Price move |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | May 2026 | −$0.06 | −$0.08 | −33.3% | Miss | −8.5%Jul 10, 2026 → Jul 14, 2026 |
| Apr 13, 2026 | Feb 2026 | −$0.10 | −$0.06 | +40.0% | Beat | +12.1%Apr 10, 2026 → Apr 14, 2026 |
| Jan 13, 2026 | Nov 2025 | −$0.13 | −$0.07 | +46.1% | Beat | +1.6%Jan 12, 2026 → Jan 14, 2026 |
| Nov 26, 2025 | Aug 2025 | −$0.16 | −$0.13 | +18.8% | Beat | +0.9%Nov 25, 2025 → Nov 28, 2025 |
| Jul 14, 2025 | May 2025 | −$0.15 | −$0.21 | −40.0% | Miss | −7.5%Jul 11, 2025 → Jul 15, 2025 |
| Apr 14, 2025 | Feb 2025 | −$0.16 | −$0.15 | +6.3% | Beat | +5.9%Apr 11, 2025 → Apr 15, 2025 |
| Jan 10, 2025 | Nov 2024 | −$0.12 | −$0.16 | −33.3% | Miss | −6.8%Jan 8, 2025 → Jan 13, 2025 |
| Nov 26, 2024 | Aug 2024 | −$0.11 | −$0.15 | −36.4% | Miss | −2.8%Nov 25, 2024 → Nov 27, 2024 |
EPS is the adjusted figure; the estimate is the consensus before the report. Price move: from the close of the trading day before the report to the close of the trading day after it — the two-day window covers both before-open and after-close reports.
Don't miss LEXX's next report
Add the stock to your watchlist — 2 days before the report you get a Telegram and on-site reminder with the expected EPS, the previous surprise and your own notes. The dashboard has LEXX's chart, metrics and signals.
No card required.
How to read this page
EPS (earnings per share) is the company's quarterly net income divided by its share count. The market doesn't judge it in isolation but against the analysts' estimate — the consensus.
An earnings surprise is how far the actual figure landed from the estimate. Some companies beat consistently, but that doesn't guarantee the next quarter will be the same.
The price reaction doesn't always match the result: a stock can fall on a good EPS print because the market also weighs revenue, guidance and margins. The move the options market prices in before the report is the expected move; a sustained one-directional move afterwards is post-earnings drift.
Frequently asked questions
- When does LEXX report earnings next?
- Lexaria Bioscience Corp. is expected to report on November 25, 2026 (time not announced). The date comes from the Nasdaq calendar and may not be officially confirmed.
- Has LEXX beaten estimates recently?
- Over the last 8 quarters Lexaria Bioscience Corp. beat the EPS estimate 4 times and missed 4 times. Median surprise: −13.5%.
- How much does LEXX stock usually move after earnings?
- Over the last 8 reports LEXX moved ±5.8% on average around the report (from the close before to the close after), with the largest move at ±12.1%. This is history, not a forecast for the next report.
- What is the EPS estimate (consensus)?
- The consensus is the average of the EPS forecasts of the analysts covering the company. The report is measured against exactly this number: above it is a beat, below it is a miss.
- Where does this data come from?
- Report dates, EPS estimates and actuals come from the Nasdaq earnings calendar, which we have archived day by day since January 1, 2024. The price move is computed from daily closing prices stored in Limitup's database. Revenue estimates are not shown — free sources don't cover every company reliably.
For information only, not investment advice. Past earnings results don't guarantee future results. Sources can contain errors — check the company's official release before an important decision.